Standout Papers
Citation Impact
Citing Papers
Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial
2006
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma
2008
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006
EGFR Antagonists in Cancer Treatment
2008 Standout
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
2001
Targeting hypoxia in cancer therapy
2011 Standout
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial
2006
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Chemical Radiosensitizers for Use in Radiotherapy
2007
Drug penetration in solid tumours
2006 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
2011
Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy
2017
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Nasopharyngeal carcinoma
2019 Standout
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer
2001
Treatment of head and neck cancer: the role of chemotherapy
1996
Individual patients' data meta-analyses in head and neck cancer
2007
The molecular biology of head and neck cancer
2010 Standout
Toxicity in head and neck cancer: a review of trends and issues
2000
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
1994 Standout
Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma
2007
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Global cancer statistics
2011 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update
2007
Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
2005
Nasopharyngeal carcinoma
2015 Standout
The pathobiology of mucositis
2004 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.
1997
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
2003
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial
2001
Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial
2003
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
2004
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial
2002
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C
1993
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
The molecular landscape of head and neck cancer
2018 Standout
A Phase III Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients With Nasopharyngeal Carcinoma
2011
Prevalence of anemia in cancer patients undergoing radiation therapy
2001
Feasibility and Efficacy of Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined with Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer
2009
Radiotherapy for cancer of the head and neck: altered fractionation regimens
2002
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Pre- or Postoperative Radiotherapy in Rectal and Rectosigmoid Carcinoma Report from a Randomized Multicenter Trial
1990
Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial
1993
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
2009 Standout
Cancer as an evolutionary and ecological process
2006 Standout
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
1993
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
2011
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Anemia of Chronic Disease
2005 Standout
Head and Neck Cancer
2001 Standout
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer
2006
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
2012
Head and Neck Cancer
2020 Standout
Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer
2007
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
2005
Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy
2008
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
2009
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018
Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
2005
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
2006
Works of W. Dobrowsky being referenced
Combined modality treatment of advanced cancers of the oral cavity and oropharynx
1991
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer
1998
AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: Results of an IAEA multicentre randomised trial
2006
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer
1989
Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy
1989
Mitomycin C (MMC) and Unconventional Fractionation (V-Chart) in Advanced Head and Neck Cancer
1995
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
2000
Conventional vs accelerated fractionation in head and neck cancer.
1996
Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis
2004
Radiotherapy of presacral recurrence following radical surgery for rectal carcinoma
1985
Unconventional fractionation with or without mitomycin C in advanced head and neck cancer
1992
Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data
2002
7 Continuous hyperfractionated accelerated radiotherapy and mitomycin C in head and neck cancer
1999
Electron beam therapy in treatment of parotid neoplasm
1986